Endocrine Regulation of the Fasting Response by PPARα-Mediated Induction of Fibroblast Growth Factor 21

Cell Metabolism

Volumn 5, Issue 6, 2007, Pages 415-425

  Inagaki, Takeshi ^a   Dutchak, Paul ^a   Zhao, Guixiang ^a   Ding, Xunshan ^a,b   Gautron, Laurent ^a,b   Parameswara, Vinay ^b   Li, Yong ^c   Goetz, Regina ^d   Mohammadi, Moosa ^d   Esser, Victoria ^b   Elmquist, Joel K ^a,b   Gerard, Robert D ^a,b   Burgess, Shawn C ^a   Hammer, Robert E ^b   Mangelsdorf, David J ^a,b   Kliewer, Steven A ^a,b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c VAN ANDEL RESEARCH INSTITUTE   (United States)

^d NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

HUMDISEASE

Indexed keywords

ANTILIPEMIC AGENT; FAT; FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 21; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA AGONIST; UNCLASSIFIED DRUG;

ADAPTATION; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL ENERGY; CONTROLLED STUDY; DIET RESTRICTION; DRUG TARGETING; DYSLIPIDEMIA; HIBERNATION; HORMONAL REGULATION; HUMAN; HUMAN CELL; HYPOTHERMIA; KETOGENESIS; LIPOLYSIS; LIVER; METABOLIC REGULATION; MOUSE; NONHUMAN; PHYSICAL ACTIVITY; PLEIOTROPY; PRIORITY JOURNAL; PROTEIN INDUCTION; SIGNAL TRANSDUCTION; STARVATION; WHITE ADIPOSE TISSUE;

ADENOVIRIDAE; ADIPOSE TISSUE; ANIMALS; CELLS, CULTURED; CHROMATIN IMMUNOPRECIPITATION; FASTING; FEMALE; FIBROBLAST GROWTH FACTORS; HEPATOCYTES; HUMANS; IMMUNOBLOTTING; LIPOLYSIS; LIVER; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; PLASMIDS; PPAR ALPHA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION; TRANSFECTION;

EID: 34249686631     PISSN: 15504131     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cmet.2007.05.003     Document Type: Article

References (53)

1. Andrews M.T., Squire T.L., Bowen C.M., and Rollins M.B. Low-temperature carbon utilization is regulated by novel gene activity in the heart of a hibernating mammal. Proc. Natl. Acad. Sci. USA 95 (1998) 8392-8397
2. Aoki K., Barker C., Danthinne X., Imperiale M.J., and Nabel G.J. Efficient generation of recombinant adenoviral vectors by Cre-lox recombination in vitro. Mol. Med. 5 (1999) 224-231
3. Avogaro A., Cryer P.E., and Bier D.M. Epinephrine's ketogenic effect in humans is mediated principally by lipolysis. Am. J. Physiol. 263 (1992) E250-E260
4. Baar R.A., Dingfelder C.S., Smith L.A., Bernlohr D.A., Wu C., Lange A.J., and Parks E.J. Investigation of in vivo fatty acid metabolism in AFABP/aP2(-/-) mice. Am. J. Physiol. Endocrinol. Metab. 288 (2005) E187-E193
5. Badman M.K., Pissios P., Kennedy A.R., Koukos G., Flier J.S., and Maratos-Flier E. Hepatic fibroblast growth factor 21 is regulated by PPARα and is a key mediator of hepatic lipid metabolism in ketotic states. Cell Metab. 5 (2007) 426-437 this issue
6. Bates M.W., Linn L.C., and Huen A.H. Effects of oleic acid infusion on plasma free fatty acids and blood ketone bodies in the fasting rat. Metabolism 25 (1976) 361-373
7. Bauer V.W., Squire T.L., Lowe M.E., and Andrews M.T. Expression of a chimeric retroviral-lipase mRNA confers enhanced lipolysis in a hibernating mammal. Am. J. Physiol. Regul. Integr. Comp. Physiol. 281 (2001) R1186-R1192
8. Beylot M., Beaufrere B., Riou J.P., Khalfallah Y., Moneger A., Odeon M., Cohen R., and Mornex R. Effect of epinephrine on the relationship between nonesterified fatty acid availability and ketone body production in postabsorptive man: evidence for a hepatic antiketogenic effect of epinephrine. J. Clin. Endocrinol. Metab. 65 (1987) 914-921
9. Bookout A.L., and Mangelsdorf D.J. Quantitative real-time PCR protocol for analysis of nuclear receptor signaling pathways. Nucl. Recept. Signal. 1 (2003) e012
10. Brown P.J., Stuart L.W., Hurley K.P., Lewis M.C., Winegar D.A., Wilson J.G., Wilkison W.O., Ittoop O.R., and Willson T.M. Identification of a subtype selective human PPARalpha agonist through parallel-array synthesis. Bioorg. Med. Chem. Lett. 11 (2001) 1225-1227
11. Burgess S.C., Hausler N., Merritt M., Jeffrey F.M., Storey C., Milde A., Koshy S., Lindner J., Magnuson M.A., Malloy C.R., and Sherry A.D. Impaired tricarboxylic acid cycle activity in mouse livers lacking cytosolic phosphoenolpyruvate carboxykinase. J. Biol. Chem. 279 (2004) 48941-48949
12. Cahill G.F. Fuel metabolism in starvation. Annu. Rev. Nutr. 26 (2006) 1-22
13. Chou C.J., Haluzik M., Gregory C., Dietz K.R., Vinson C., Gavrilova O., and Reitman M.L. WY14,643, a peroxisome proliferator-activated receptor alpha (PPARalpha) agonist, improves hepatic and muscle steatosis and reverses insulin resistance in lipoatrophic A-ZIP/F-1 mice. J. Biol. Chem. 277 (2002) 24484-24489
14. Collins S., Cao W., and Robidoux J. Learning new tricks from old dogs: beta-adrenergic receptors teach new lessons on firing up adipose tissue metabolism. Mol. Endocrinol. 18 (2004) 2123-2131
15. Dark J., Miller D.R., Lewis D.A., Fried S.K., and Bunkin D. Noradrenaline-induced lipolysis in adipose tissue is suppressed at hibernation temperatures in ground squirrels. J. Neuroendocrinol. 15 (2003) 451-458
16. Drynan L., Quant P.A., and Zammit V.A. Flux control exerted by mitochondrial outer membrane carnitine palmitoyltransferase over beta-oxidation, ketogenesis and tricarboxylic acid cycle activity in hepatocytes isolated from rats in different metabolic states. Biochem. J. 317 (1996) 791-795
17. Erol E., Kumar L.S., Cline G.W., Shulman G.I., Kelly D.P., and Binas B. Liver fatty acid binding protein is required for high rates of hepatic fatty acid oxidation but not for the action of PPARalpha in fasting mice. FASEB J. 18 (2004) 347-349
18. Esser V., Kuwajima M., Britton C.H., Krishnan K., Foster D.W., and McGarry J.D. Inhibitors of mitochondrial carnitine palmitoyltransferase I limit the action of proteases on the enzyme. Isolation and partial amino acid analysis of a truncated form of the rat liver isozyme. J. Biol. Chem. 268 (1993) 5810-5816
19. Folch J., Lees M., and Sloane Stanley G.H. A simple method for the isolation and purification of total lipides from animal tissues. J. Biol. Chem. 226 (1957) 497-509
20. Fredrikson G., Stralfors P., Nilsson N.O., and Belfrage P. Hormone-sensitive lipase of rat adipose tissue. Purification and some properties. J. Biol. Chem. 256 (1981) 6311-6320
21. Fukao T., Lopaschuk G.D., and Mitchell G.A. Pathways and control of ketone body metabolism: on the fringe of lipid biochemistry. Prostaglandins Leukot. Essent. Fatty Acids 70 (2004) 243-251
22. Geiser F. Metabolic rate and body temperature reduction during hibernation and daily torpor. Annu. Rev. Physiol. 66 (2004) 239-274
23. Gerard R.D., and Meidell R.S. Adenovirus vectors. In: Glover D.M., and Hames B.D. (Eds). DNA Cloning 4: A Practical Approach: Mammalian Systems (1995), Oxford University Press, Oxford 285-307
24. Guerre-Millo M., Gervois P., Raspe E., Madsen L., Poulain P., Derudas B., Herbert J.M., Winegar D.A., Willson T.M., Fruchart J.C., et al. Peroxisome proliferator-activated receptor alpha activators improve insulin sensitivity and reduce adiposity. J. Biol. Chem. 275 (2000) 16638-16642
25. Hashimoto T., Cook W.S., Qi C., Yeldandi A.V., Reddy J.K., and Rao M.S. Defect in peroxisome proliferator-activated receptor alpha-inducible fatty acid oxidation determines the severity of hepatic steatosis in response to fasting. J. Biol. Chem. 275 (2000) 28918-28928
26. Hegardt F.G. Mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase: a control enzyme in ketogenesis. Biochem. J. 338 (1999) 569-582
27. Houten S.M. Homing in on bile acid physiology. Cell Metab. 4 (2006) 423-424
28. Hsu M.H., Savas U., Griffin K.J., and Johnson E.F. Identification of peroxisome proliferator-responsive human genes by elevated expression of the peroxisome proliferator-activated receptor alpha in HepG2 cells. J. Biol. Chem. 276 (2001) 27950-27958
29. Inagaki T., Choi M., Moschetta A., Peng L., Cummins C.L., McDonald J.G., Luo G., Jones S.A., Goodwin B., Richardson J.A., et al. Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis. Cell Metab. 2 (2005) 217-225
30. Itoh N., and Ornitz D.M. Evolution of the Fgf and Fgfr gene families. Trends Genet. 20 (2004) 563-569
31. Kersten S., Seydoux J., Peters J.M., Gonzalez F.J., Desvergne B., and Wahli W. Peroxisome proliferator-activated receptor alpha mediates the adaptive response to fasting. J. Clin. Invest. 103 (1999) 1489-1498
32. Kersten S., Desvergne B., and Wahli W. Roles of PPARs in health and disease. Nature 405 (2000) 421-424
33. Kharitonenkov A., Shiyanova T.L., Koester A., Ford A.M., Micanovic R., Galbreath E.J., Sandusky G.E., Hammond L.J., Moyers J.S., Owens R.A., et al. FGF-21 as a novel metabolic regulator. J. Clin. Invest. 115 (2005) 1627-1635
34. Kharitonenkov A., Wroblewski V.J., Koester A., Chen Y.F., Clutinger C.K., Tigno X.T., Hansen B.C., Shanafelt A.B., and Etgen G.J. The metabolic state of diabetic monkeys is regulated by fibroblast growth factor-21. Endocrinology 148 (2007) 774-781 10.1210/en.2006-1168 Published online October 26, 2006
35. Kolek O.I., Hines E.R., Jones M.D., LeSueur L.K., Lipko M.A., Kiela P.R., Collins J.F., Haussler M.R., and Ghishan F.K. 1alpha,25-Dihydroxyvitamin D3 upregulates FGF23 gene expression in bone: the final link in a renal-gastrointestinal-skeletal axis that controls phosphate transport. Am. J. Physiol. Gastrointest. Liver Physiol. 289 (2005) G1036-G1042
36. Krilowicz B.L. Ketone body metabolism in a ground squirrel during hibernation and fasting. Am. J. Physiol. 249 (1985) R462-R470
37. Lefebvre P., Chinetti G., Fruchart J.C., and Staels B. Sorting out the roles of PPAR alpha in energy metabolism and vascular homeostasis. J. Clin. Invest. 116 (2006) 571-580
38. Leone T.C., Weinheimer C.J., and Kelly D.P. A critical role for the peroxisome proliferator-activated receptor alpha (PPARalpha) in the cellular fasting response: the PPARalpha-null mouse as a model of fatty acid oxidation disorders. Proc. Natl. Acad. Sci. USA 96 (1999) 7473-7478
39. Li J., Pircher P.C., Schulman I.G., and Westin S.K. Regulation of complement C3 expression by the bile acid receptor FXR. J. Biol. Chem. 280 (2005) 7427-7434
40. Miyake J.H., Doung X.D., Strauss W., Moore G.L., Castellani L.W., Curtiss L.K., Taylor J.M., and Davis R.A. Increased production of apolipoprotein B-containing lipoproteins in the absence of hyperlipidemia in transgenic mice expressing cholesterol 7alpha-hydroxylase. J. Biol. Chem. 276 (2001) 23304-23311
41. Moreau-Hamsany C., Castex C., Hoo-Paris R., Kacemi N., and Sutter B. Hormonal control of lipolysis from the white adipose tissue of hibernating jerboa (Jaculus orientalis). Comp. Biochem. Physiol. A 91 (1988) 665-669
42. Plotnikov A.N., Hubbard S.R., Schlessinger J., and Mohammadi M. Crystal structures of two FGF-FGFR complexes reveal the determinants of ligand-receptor specificity. Cell 101 (2000) 413-424
43. Rauch J.C., and Behrisch H.W. Ketone bodies: a source of energy during hibernation. Can. J. Zool. 59 (1981) 754-760
44. Rodriguez J.C., Gil-Gomez G., Hegardt F.G., and Haro D. Peroxisome proliferator-activated receptor mediates induction of the mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase gene by fatty acids. J. Biol. Chem. 269 (1994) 18767-18772
45. Scholz R., Schwabe U., and Soboll S. Influence of fatty acids on energy metabolism. 1. Stimulation of oxygen consumption, ketogenesis and CO2 production following addition of octanoate and oleate in perfused rat liver. Eur. J. Biochem. 141 (1984) 223-230
46. Shimano H., Horton J.D., Hammer R.E., Shimomura I., Brown M.S., and Goldstein J.L. Overproduction of cholesterol and fatty acids causes massive liver enlargement in transgenic mice expressing truncated SREBP-1a. J. Clin. Invest. 98 (1996) 1575-1584
47. Simonet W.S., Bucay N., Lauer S.J., and Taylor J.M. A far-downstream hepatocyte-specific control region directs expression of the linked human apolipoprotein E and C-I genes in transgenic mice. J. Biol. Chem. 268 (1993) 8221-8229
48. Student A.K., Hsu R.Y., and Lane M.D. Induction of fatty acid synthetase synthesis in differentiating 3T3-L1 preadipocytes. J. Biol. Chem. 255 (1980) 4745-4750
49. Tsuchida A., Yamauchi T., Takekawa S., Hada Y., Ito Y., Maki T., and Kadowaki T. Peroxisome proliferator-activated receptor (PPAR)alpha activation increases adiponectin receptors and reduces obesity-related inflammation in adipose tissue: comparison of activation of PPARalpha, PPARgamma, and their combination. Diabetes 54 (2005) 3358-3370
50. Tugwood J.D., Issemann I., Anderson R.G., Bundell K.R., McPheat W.L., and Green S. The mouse peroxisome proliferator activated receptor recognizes a response element in the 5′ flanking sequence of the rat acyl CoA oxidase gene. EMBO J. 11 (1992) 433-439
51. Winegar D.A., Brown P.J., Wilkison W.O., Lewis M.C., Ott R.J., Tong W.Q., Brown H.R., Lehmann J.M., Kliewer S.A., Plunket K.D., et al. Effects of fenofibrate on lipid parameters in obese rhesus monkeys. J. Lipid Res. 42 (2001) 1543-1551
52. Yu X., and White K.E. FGF23 and disorders of phosphate homeostasis. Cytokine Growth Factor Rev. 16 (2005) 221-232
53. Zhang J., Kaasik K., Blackburn M.R., and Lee C.C. Constant darkness is a circadian metabolic signal in mammals. Nature 439 (2006) 340-343